These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15659058

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [HERG K+ channel, the target of anti-arrhythmias drugs].
    Guan FY, Yang SJ.
    Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes.
    Turker I, Ai T, Itoh H, Horie M.
    Pharmacol Ther; 2017 Aug; 176():48-59. PubMed ID: 28527921
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phenotypic manifestations of mutations in genes encoding subunits of cardiac potassium channels.
    Shimizu W, Horie M.
    Circ Res; 2011 Jun 24; 109(1):97-109. PubMed ID: 21700951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Short QT syndrome. What is it? Where is it?
    Puri VK, Dwivedi SK, Puri A, Behal K.
    Indian Heart J; 2005 Jun 24; 57(6):769-71. PubMed ID: 16521657
    [No Abstract] [Full Text] [Related]

  • 12. The hERG K+ channel: target and antitarget strategies in drug development.
    Raschi E, Vasina V, Poluzzi E, De Ponti F.
    Pharmacol Res; 2008 Mar 24; 57(3):181-95. PubMed ID: 18329284
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Failure of antiarrhythmia agents and understanding the phenomenon of proarrhythmia].
    Semrád B.
    Vnitr Lek; 2003 Sep 24; 49(9):700-6. PubMed ID: 14584417
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
    ter Bekke RM, Haugaa KH, van den Wijngaard A, Bos JM, Ackerman MJ, Edvardsen T, Volders PG.
    Eur Heart J; 2015 Jan 14; 36(3):179-86. PubMed ID: 25205533
    [Abstract] [Full Text] [Related]

  • 20. Clinical Features of Genetic Cardiac Diseases Related to Potassium Channelopathies.
    Adler A, Viskin S.
    Card Electrophysiol Clin; 2016 Jun 14; 8(2):361-72. PubMed ID: 27261827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.